Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Covington
Daiichi Sankyo
Johnson and Johnson
Harvard Business School
AstraZeneca
Accenture
Deloitte

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076841

« Back to Dashboard

NDA 076841 describes MESALAMINE, which is a drug marketed by G And W Labs Inc, Perrigo Israel, Mylan Pharms Inc, Actavis Labs Fl, and Zydus Pharms Usa Inc, and is included in six NDAs. It is available from four suppliers. Additional details are available on the MESALAMINE profile page.

The generic ingredient in MESALAMINE is mesalamine. There are twenty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
Summary for 076841
Tradename:MESALAMINE
Applicant:G And W Labs Inc
Ingredient:mesalamine
Patents:0
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076841

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:ENEMA;RECTALStrength4GM/60ML
Approval Date:Sep 30, 2004TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Cerilliant
Dow
Healthtrust
Boehringer Ingelheim
McKinsey
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.